Pierre Blanchard
A5011183093- Head and Neck Cancer Studies
- Advanced Radiotherapy Techniques
- Prostate Cancer Diagnosis and Treatment
- Prostate Cancer Treatment and Research
- Head and Neck Surgical Oncology
- Lung Cancer Diagnosis and Treatment
- Radiomics and Machine Learning in Medical Imaging
- Lung Cancer Research Studies
- Lung Cancer Treatments and Mutations
- Advances in Oncology and Radiotherapy
- Cancer Diagnosis and Treatment
- Radiation Therapy and Dosimetry
- Firm Innovation and Growth
- Ear and Head Tumors
- Salivary Gland Tumors Diagnosis and Treatment
- Esophageal Cancer Research and Treatment
- Colorectal and Anal Carcinomas
- Management of metastatic bone disease
- Global trade and economics
- Bladder and Urothelial Cancer Treatments
- Urologic and reproductive health conditions
- Brain Metastases and Treatment
- Oral health in cancer treatment
- Medical Imaging Techniques and Applications
- Radiation Dose and Imaging
Université Paris-Saclay
2015-2025
Institut Gustave Roussy
2016-2025
Inserm
2016-2025
Centre de recherche en Epidémiologie et Santé des Populations
2015-2025
Union for International Cancer Control
2024
La Ligue Contre le Cancer
2016-2023
Groupe d'Oncologie Radiothérapie Tête et Cou
2013-2023
Institut de Recherche contre les Cancers de l’Appareil Digestif
2022
The University of Texas MD Anderson Cancer Center
2016-2021
Université Paris-Sud
2012-2021
Purpose The role of adjuvant chemotherapy (AC) or induction (IC) in the treatment locally advanced nasopharyngeal carcinoma is controversial. individual patient data from Meta-Analysis Chemotherapy Nasopharynx Carcinoma database were used to compare all available treatments. Methods All randomized trials radiotherapy (RT) with without nonmetastatic considered. Overall, 20 and 5,144 patients included. Treatments grouped into seven categories: RT alone (RT), IC followed by (IC-RT), AC (RT-AC),...
Owing to its physical properties, intensity-modulated proton therapy (IMPT) used for patients with oropharyngeal carcinoma has the ability reduce dose organs at risk compared radiotherapy (IMRT) while maintaining adequate tumor coverage. Our aim was compare clinical outcomes of these two treatment modalities.
Because of the unprecedented disruption health care services caused by COVID-19 pandemic, American Society Radiation Oncology (ASTRO) and European for Radiotherapy (ESTRO) identified an urgent need to issue practice recommendations radiation oncologists treating head neck cancer (HNC) in a time limited resources heightened risk patients staff.
Innovations in imaging and molecular characterisation the evolution of new therapies have improved outcomes advanced prostate cancer. Nonetheless, we continue to lack high-level evidence on a variety clinical topics that greatly impact daily practice. To supplement evidence-based guidelines, 2022 Advanced Prostate Cancer Consensus Conference (APCCC 2022) surveyed experts about key dilemmas management.To present consensus voting results for select questions from APCCC 2022.Before conference,...
Innovations have improved outcomes in advanced prostate cancer (PC). Nonetheless, we continue to lack high-level evidence on a variety of topics that greatly impact daily practice. The 2024 Advanced Prostate Cancer Consensus Conference (APCCC) surveyed experts key questions clinical management order supplement evidence-based guidelines. Here present voting results for from APCCC 2024.
The aim of this article is to assess the impact obstacles innovation on firms’ propensity innovate. We show that distinguishing between firms do not innovate because they intend and try but fail or give up insurmountable key for properly measuring barriers innovation. Estimating an production function appropriately defined subsamples allows obtaining consistent results, i.e. a significant negative These results are robust definition these subsamples, way “obstacles innovation” defined, as...